Patient‐reported outcomes from the investigational device exemption study of the Tablo hemodialysis system

por Chertow, Glenn M., Alvarez, Luis, Plumb, Troy J., Prichard, Sarah S., Aragon, Michael
Publicado 2020

Extension of Tablo TrEatmeNt Duration (XTEND) study: successful 24 h prolonged therapy with Tablo in critical patients

por Zaman, Tahir, Moore, Kasadi, Jellerson, Jennifer, Chahal, Yaadveer, Schumacher, Joshua, Dalessandri-Silva, Cynthia, Aragon, Michael
Publicado 2022

Severe methanol poisoning treated with a novel hemodialysis system: a case report, analysis, and review

por Illescas, Alisa C., Argyropoulos, Christos P., Combs, Sara A., Shaffi, Saeed K., Xu, Zhi Q., Aragon, Michael A., Teixeira, J. Pedro
Publicado 2021

Safety and efficacy of the Tablo hemodialysis system for in‐center and home hemodialysis

por Plumb, Troy J., Alvarez, Luis, Ross, Dennis L., Lee, Joseph J., Mulhern, Jeffrey G., Bell, Jeffrey L., Abra, Graham, Prichard, Sarah S., Chertow, Glenn M., Aragon, Michael A.
Publicado 2019

Self‐care training using the Tablo hemodialysis system

por Plumb, Troy J., Alvarez, Luis, Ross, Dennis L., Lee, Joseph J., Mulhern, Jeffrey G., Bell, Jeffrey L., Abra, Graham E., Prichard, Sarah S., Chertow, Glenn M., Aragon, Michael A.
Publicado 2020